They have shown that inhibition of C-X-C motif chemokine 12 (CXCL12) (also known as the stromal cell-derived factor 1 [SDF-1]) attenuates obliterative bronchiolitis in a murine heterotopic tracheal transplant model. This evidence concerns the gene CXCL12 and bronchiolitis obliterans syndrome.